AWARE - Chronic Urticaria
NCT02435238 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2018-02-15
Summary
Non interventional study collecting patient reported outcomes. The study aims to assess the disease burden of chronic urticaria patients and to record the therapies used in daily clinical practice in the UK and the impact they have on the quality of life and work productivity of individual patients.
Conditions
- Chronic Urticaria
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-03
- Primary Completion
- 2017-09-27
- Completion
- 2017-09-27
Countries
- United Kingdom
Study Locations
More Related Trials
-
This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines
NCT03926611 ·Status: COMPLETED ·Phase: PHASE2
-
Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria
NCT04314999 ·Status: COMPLETED
-
CUTE (Chronic Urticaria Treatment Evaluation)
NCT00264303 ·Status: COMPLETED ·Phase: PHASE4
-
Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
NCT02000648 ·Status: COMPLETED
-
Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis
NCT00524836 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.
NCT05373355 ·Status: COMPLETED ·Phase: PHASE1
-
Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
NCT05210543 ·Status: RECRUITING
-
Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria
NCT06072157 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers
NCT00483353 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist
NCT03293225 ·Status: COMPLETED
-
Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria
NCT04853992 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Efficacy and Safety of TLL-018 in CSU Participants
NCT06396026 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Nasal Inflammatory Biomarkers
NCT03450031 ·Status: COMPLETED ·Phase: NA
-
Detection of Viral Particels in Urticaria Patients
NCT03151902 ·Status: COMPLETED
-
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
NCT00453583 ·Status: COMPLETED
-
EWO1 in Persistent Allergic Rhinitis Patients
NCT00153595 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis
NCT00952835 ·Status: UNKNOWN
-
A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).
NCT03137069 ·Status: COMPLETED ·Phase: PHASE2
-
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
NCT06927999 ·Status: RECRUITING ·Phase: PHASE2
-
Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001
NCT06577116 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare Digital Disease Monitoring of Patients With csU (Telemedicine to Face-to-Face Visits) in Germany
NCT06991608 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria
NCT00421109 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis
NCT01748344 ·Status: COMPLETED ·Phase: PHASE2
-
To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
NCT04426890 ·Status: COMPLETED ·Phase: PHASE3
-
Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis
NCT00232518 ·Status: COMPLETED ·Phase: NA